XPH
XPH
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 OGN | Organon & Co. | 3.76% | 998.93K | $13.34M |
 CORT | Corcept Therapeutics Incorporated | 3.66% | 189.48K | $12.96M |
 LQDA | Liquidia Corporation | 2.90% | 165.80K | $10.28M |
 AXSM | Axsome Therapeutics, Inc. | 2.63% | 40.08K | $9.33M |
 ELVN | Enliven Therapeutics, Inc. | 2.39% | 208.25K | $8.47M |
 JAZZ | Jazz Pharmaceuticals plc | 2.29% | 34.48K | $8.12M |
 DFTX | Definium Therapeutics, Inc. | 2.27% | 343.17K | $8.06M |
 TRVI | Trevi Therapeutics, Inc. | 2.18% | 535.44K | $7.74M |
 RPRX | Royalty Pharma plc | 2.11% | 136.93K | $7.46M |
 ESPR | Esperion Therapeutics, Inc. | 2.10% | 2.38M | $7.44M |
 VTRS | Viatris Inc. | 2.08% | 457.63K | $7.37M |
 PRGO | Perrigo Company plc | 2.05% | 651.70K | $7.27M |
 LLY | Eli Lilly and Company | 2.03% | 6.39K | $7.20M |
 INDV | Indivior Pharmaceuticals Inc | 2.01% | 194.74K | $7.13M |
 HRMY | Harmony Biosciences Holdings, Inc. | 1.97% | 222.06K | $6.99M |
 MBX | MBX Biosciences, Inc. Common Stock | 1.96% | 217.40K | $6.93M |
 EWTX | Edgewise Therapeutics, Inc. | 1.94% | 206.30K | $6.87M |
 ANIP | ANI Pharmaceuticals, Inc. | 1.92% | 83.80K | $6.80M |
 LGND | Ligand Pharmaceuticals Incorporated | 1.91% | 28.90K | $6.78M |
 XERS | Xeris Biopharma Holdings, Inc. | 1.89% | 1.06M | $6.68M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
Cayman Islands
SingaporeSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland Cayman Islands SingaporeHoldings (Top 20)
OGN
Organon & Co.
CORT
Corcept Therapeutics Incorporated
LQDA
Liquidia Corporation
AXSM
Axsome Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
JAZZ
Jazz Pharmaceuticals plc
DFTX
Definium Therapeutics, Inc.
TRVI
Trevi Therapeutics, Inc.
RPRX
Royalty Pharma plc
ESPR
Esperion Therapeutics, Inc.
VTRS
Viatris Inc.
PRGO
Perrigo Company plc
LLY
Eli Lilly and Company
INDV
Indivior Pharmaceuticals Inc
HRMY
Harmony Biosciences Holdings, Inc.
MBX
MBX Biosciences, Inc. Common Stock
EWTX
Edgewise Therapeutics, Inc.
ANIP
ANI Pharmaceuticals, Inc.
LGND
Ligand Pharmaceuticals Incorporated
XERS
Xeris Biopharma Holdings, Inc.